Ask AI

Genitourinary Cancers

David F. McDermott MD and Daniel P. Petrylak MD review data from key genitourinary cancer presentations from the 2015 clinical oncology meeting in Chicago.

Share

Program Content

Activities

  • Lenvatinib ± Everolimus in mRCC
    Improved Survival and Response With Lenvatinib ± Everolimus vs Everolimus Alone in Metastatic RCC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

AstraZeneca

Bayer Healthcare Pharma

Bristol Myers Squibb

Celgene

Genentech BioOncology

Incyte

Novartis Pharmaceuticals Corporation